322 related articles for article (PubMed ID: 10545954)
21. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
[TBL] [Abstract][Full Text] [Related]
22. Requirement of the yeast MSH3 and MSH6 genes for MSH2-dependent genomic stability.
Johnson RE; Kovvali GK; Prakash L; Prakash S
J Biol Chem; 1996 Mar; 271(13):7285-8. PubMed ID: 8631743
[TBL] [Abstract][Full Text] [Related]
23. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
[TBL] [Abstract][Full Text] [Related]
24. Msh2 separation of function mutations confer defects in the initiation steps of mismatch repair.
Kijas AW; Studamire B; Alani E
J Mol Biol; 2003 Aug; 331(1):123-38. PubMed ID: 12875840
[TBL] [Abstract][Full Text] [Related]
25. MSH6 germline mutations are rare in colorectal cancer families.
Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
[TBL] [Abstract][Full Text] [Related]
26. Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern.
Wiesendanger M; Kneitz B; Edelmann W; Scharff MD
J Exp Med; 2000 Feb; 191(3):579-84. PubMed ID: 10662804
[TBL] [Abstract][Full Text] [Related]
27. Mismatch repair deficiency associated with overexpression of the MSH3 gene.
Marra G; Iaccarino I; Lettieri T; Roscilli G; Delmastro P; Jiricny J
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8568-73. PubMed ID: 9671718
[TBL] [Abstract][Full Text] [Related]
28. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
29. MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites.
Roa S; Li Z; Peled JU; Zhao C; Edelmann W; Scharff MD
PLoS One; 2010 Jun; 5(6):e11182. PubMed ID: 20567595
[TBL] [Abstract][Full Text] [Related]
30. Chimeric Saccharomyces cerevisiae Msh6 protein with an Msh3 mispair-binding domain combines properties of both proteins.
Shell SS; Putnam CD; Kolodner RD
Proc Natl Acad Sci U S A; 2007 Jun; 104(26):10956-61. PubMed ID: 17573527
[TBL] [Abstract][Full Text] [Related]
31. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
de Vos M; Hayward B; Bonthron DT; Sheridan E
Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
[TBL] [Abstract][Full Text] [Related]
32. Association of low-risk MSH3 and MSH2 variant alleles with Lynch syndrome: probability of synergistic effects.
Duraturo F; Liccardo R; Cavallo A; De Rosa M; Grosso M; Izzo P
Int J Cancer; 2011 Oct; 129(7):1643-50. PubMed ID: 21128252
[TBL] [Abstract][Full Text] [Related]
33. Functional interaction of proliferating cell nuclear antigen with MSH2-MSH6 and MSH2-MSH3 complexes.
Clark AB; Valle F; Drotschmann K; Gary RK; Kunkel TA
J Biol Chem; 2000 Nov; 275(47):36498-501. PubMed ID: 11005803
[TBL] [Abstract][Full Text] [Related]
34. MutS homologs in mammalian cells.
Fishel R; Wilson T
Curr Opin Genet Dev; 1997 Feb; 7(1):105-13. PubMed ID: 9024626
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
de Wind N; Dekker M; Berns A; Radman M; te Riele H
Cell; 1995 Jul; 82(2):321-30. PubMed ID: 7628020
[TBL] [Abstract][Full Text] [Related]
36. Novel germline mutation (300-305delAGTTGA) in the human MSH2 gene in hereditary non-polyposis colorectal cancer (HNPCC).
Glasl S; Papatheodorou L; Baretton G; Jung C; Gross M
Hum Mutat; 2000 Jul; 16(1):91-2. PubMed ID: 10874318
[TBL] [Abstract][Full Text] [Related]
37. A lack of DNA mismatch repair on an athymic murine background predisposes to hematologic malignancy.
Campbell MR; Nation PN; Andrew SE
Cancer Res; 2005 Apr; 65(7):2626-35. PubMed ID: 15805259
[TBL] [Abstract][Full Text] [Related]
38. Mutator phenotype in Msh2-deficient murine embryonic fibroblasts.
Reitmair AH; Risley R; Bristow RG; Wilson T; Ganesh A; Jang A; Peacock J; Benchimol S; Hill RP; Mak TW; Fishel R; Meuth M
Cancer Res; 1997 Sep; 57(17):3765-71. PubMed ID: 9288785
[TBL] [Abstract][Full Text] [Related]
39. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice.
Foiry L; Dong L; Savouret C; Hubert L; te Riele H; Junien C; Gourdon G
Hum Genet; 2006 Jun; 119(5):520-6. PubMed ID: 16552576
[TBL] [Abstract][Full Text] [Related]
40. Compound heterozygosity for two MSH6 mutations in a patient with early onset of HNPCC-associated cancers, but without hematological malignancy and brain tumor.
Plaschke J; Linnebacher M; Kloor M; Gebert J; Cremer FW; Tinschert S; Aust DE; von Knebel Doeberitz M; Schackert HK
Eur J Hum Genet; 2006 May; 14(5):561-6. PubMed ID: 16418736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
